Dimagi Inc.
11
0
1
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
9%
1 trials in Phase 3/4
50%
4 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Measurement-Based Peer Supervision App for Non-Specialist Providers
Role: lead
A Chatbot To Support Substance Use Recovery
Role: lead
Adapting and Evaluating a Brief Advice Tobacco Intervention in High-Reach, Low-Resource Settings in India
Role: collaborator
PlusCare: Mobile Platform to Increase Linkage to Care in Adolescents Living With HIV/AIDS
Role: lead
m-Palliative Care Link: Improving Palliative Care for Late Stage Tanzanian Cancer Patients
Role: collaborator
ARemind: A Personalized System to Remind for Adherence
Role: lead
A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure
Role: collaborator
Mobile -Solutions Aiding Knowledge for Health Improvement
Role: collaborator
ScreenFlow: Strategy for Finding Cases of Moderate-to-Severe COPD
Role: lead
China Adherence Through Technology Study
Role: collaborator
Antiretroviral Adherence and Quality-of-life Support for HIV+ Patients in India With Twice-daily Interactive Voice Response (IVR) Calls With Health and Mental Health Messaging Compared to Weekly IVR Survey Only Control Condition: The Mobile-messaging Adherence and Support for Health Study, India.
Role: collaborator
All 11 trials loaded